Evidence map›Paper›PMID 39080233›Full record

SynthesisBiological trace element research2025

Alzheimer's Disease and Circulatory Imbalance of Toxic Heavy Metals: A Systematic Review and Meta-analysis of Clinical Studies.

Alireza Kooshki, Reyhane Farmani, Omid Mehrpour, Ali Naghizadeh, Alireza Amirabadizadeh, Sepide Kavoosi, Varun Vohra, Samaneh Nakhaee

Abstract readSystematic ReviewMeta-Analysis
PubMed Publisher
In one paragraph

Synthesis in Biological trace element research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Environmental toxins in neurodegeneration - a narrative review.Neurological research and practice · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alireza KooshkiStudent Research Committee, Birjand University of Medical Sciences, Birjand, 9717853076, Iran.
Reyhane FarmaniStudent Research Committee, Birjand University of Medical Sciences, Birjand, 9717853076, Iran.
Omid MehrpourMichigan Poison & Drug Information Center, School of Medicine, Wayne State University, Detroit, MI, 48202, USA.
Ali NaghizadehMedical Toxicology and Drug Abuse Research Center (MTDRC), Birjand University of Medical Sciences, Birjand, 9717853076, Iran.
Alireza AmirabadizadehStudent Research Committee, Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Sepide KavoosiStudent Research Committee, Birjand University of Medical Sciences, Birjand, 9717853076, Iran.
Varun VohraMichigan Poison & Drug Information Center, School of Medicine, Department of Emergency Medicine, Wayne State University, Detroit, MI, USA.
Samaneh NakhaeeMedical Toxicology and Drug Abuse Research Center (MTDRC), Birjand University of Medical Sciences, Birjand, 9717853076, Iran. nakhaee38@yahoo.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The role of heavy metals on human health has often been discussed regarding disease pathogenesis and risk factors. Alzheimer's disease (AD), a prevalent neurodegenerative disease, is no exception. We conducted a comprehensive examination to assess the concentrations of lead (Pb), cadmium (Cd), arsenic (As), and mercury (Hg) in biological samples of AD patients in comparison with a group of individuals without AD, with the objective of our study being to perform a systematic review on this topic. We performed this systematic review by searching various databases/search engines, including Web of Science, Scopus, PubMed, and Google Scholar, until December 7, 2022. Relevant studies were scrutinized for eligibility. Meta-analysis was performed on studies with sufficient data using STATA software. Twenty-seven out of 3349 studies met pre-defined eligibility criteria and were included in our systematic review. For the meta-analysis, 22 studies with 3346 participants (1291 AD patients and 2055 healthy controls) had sufficient data for inclusion in the analysis. Using a random-effects model, we found that pooled data indicated patients with AD had significantly higher levels of Cd in their biological samples compared to controls (Hedges' g, 0.83; 95% CI, 0.11, 1.54; p = 0.023). However, other heavy metals were not significantly different in circulatory samples of AD patients compared to healthy controls (p > 0.05). This systematic review and meta-analysis indicated that Cd concentrations in AD patients were significantly higher than in healthy controls. Other included heavy metals may not be directly associated with increased risk of AD.

Indexed as

Alzheimer DiseaseMetals, HeavyArsenicCadmiumHumansMercuryArsenicCadmiumMercuryMetals, HeavyAlzheimer’s diseaseArsenicCadmiumDementiaHeavy metalsLeadMercuryToxic metals

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.